Actively Recruiting
EUmetriosis: Insights Into the Pathogenesis of Endometriosis
Led by Université Catholique de Louvain · Updated on 2025-06-03
60
Participants Needed
1
Research Sites
242 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.
CONDITIONS
Official Title
EUmetriosis: Insights Into the Pathogenesis of Endometriosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Premenopausal
- In spontaneous menstrual cycle (no hormonal treatments for the last 3 months)
- Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy
- Female aged 18 to 56 years
You will not qualify if you...
- HIV or Hepatitis positive
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cliniques universitaires Saint-Luc
Brussels, Belgium, 1200
Actively Recruiting
Research Team
M
Marie-Madeleine Dolmans, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here